Skip to main content

Election of the Board of Vilkyškių pieninė AB

The Supervisory Council of Vilkyškių pieninė AB (company code 277160980, hereinafter – the Company) on 23 April 2026 elected the Board of the Company for a new term of office. Following the decision of the Supervisory Council, the Chairman of the Board was elected at the first meeting of the newly elected Board.The newly elected Board is composed of:Gintaras Bertašius – Chairman of the Board, Chief Executive Officer of Vilkyškių pieninė AB; Vilija Milaševičiutė – Member of the Board, Director of Economics and Finance of Vilkyškių pieninė AB; Sigitas Trijonis – Member of the Board, Director of the Investment Projects of Vilkyškių pieninė AB; Rimantas Jancevičius – Member of the Board, Director of Raw Material Purchase of Vilkyškių pieninė AB; Linas Strėlis – Independent Member of the Board; Andrej Cyba – Independent Member of the Board.In...

Continue reading

Vilkyškių pieninė AB annual information for the year 2025

Vilkyškių pieninė AB (company code 277160980) introduce audited seperate and consolidated annual reporting for the year 2025, approved by the Ordinary General Meeting of Shareholders, the independent auditor’s report. The Company informs that the Ex-Date, since which Vilkyškių pieninė AB shares (VLP1L, ISIN kodas LT0000127508) bought via stock exchange with settlement cycle T+2 do not provide the right to dividends for year 2025, is 11 May 2026.  Vilija MilaševičiutėEconomics and finance directorPhone: +370 441 55 102 Email: vilija.milaseviciute@vilvi.euAttachmentsabvilkyskiupienine-2025-12-31-enEN Vilkyskiu pienine CSRD_limited_assurance_report_2025Vilkyskiu pienine_auditors report_IFRS_EN_2025

Continue reading

CORRECTION – Satellogic Schedules First Quarter Fiscal Year 2026 Results Conference Call on Tuesday, May 12, 2026 at 8:00 a.m. Eastern Time

In a release issued earlier today by Satellogic, Inc. (NASDAQ: SATL), please note that in the headline, the date for the conference call was stated incorrectly as March 12, 2026. The corrected release follows: Satellogic Schedules First Quarter Fiscal Year 2026 Results Conference Call on Tuesday, May 12, 2026 at 8:00 a.m. Eastern Time NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) — Satellogic, Inc. (NASDAQ: SATL), a vertically integrated geospatial company delivering high-resolution Earth Observation (EO) at unprecedented scale and economics, will hold a conference call on Tuesday, May 12, 2026 at 8:00 a.m. Eastern time to discuss its results for the first quarter and fiscal year 2026 ended March 31, 2026, and will be providing updates on recent commercial advancements, partnerships, and other initiatives and milestones. Satellogic’s...

Continue reading

Polyrizon Announces Filing of European Patent Application for Its Breakthrough Drug Delivery Platform

Raanana, Israel, April 27, 2026 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced the filing of a divisional patent application with the Europe Patent Office for its Trap & Target (T&T) platform technology. This application focuses exclusively on protecting the Company’s advanced intranasal drug delivery system, which is designed to enhance the effectiveness of medications by increasing their residence time and ensuring close contact with mucosal tissues and aligns with the Company’s recently announced U.S. patent application which encompasses key aspects of Polyrizon’s two core platform technologies: Capture and Contain (C&C™), a nasal blocker technology, and...

Continue reading

POET Technologies Provides Purchase Order Update

SAN JOSE, Calif., April 27, 2026 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (NASDAQ: POET), a leader in the design and implementation of highly-integrated optical engines and light sources for artificial intelligence networks, today announced the cancellation of all purchase orders received by the Company from Celestial AI, including the ones for initial production units first disclosed (the “Purchase Orders”) by the Company in a press release on April 25, 2023. Marvell Semiconductor Inc., which acquired Celestial AI, provided written notice of the cancellation to the Company on April 23, 2026. As the basis for the cancellation, Marvell indicated that the Company had made disclosures of information related to the Purchase Order and shipping information in contravention...

Continue reading

Telos Corporation to Announce First Quarter 2026 Financial Results on May 11, 2026

ASHBURN, Va., April 27, 2026 (GLOBE NEWSWIRE) — Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced that it will report first quarter 2026 financial results on Monday, May 11, 2026. Management will host a webcast to discuss the Company’s financial results and business outlook at 9:30 a.m. ET.What: Telos Corporation First Quarter 2026 Financial Results WebcastWhen: Monday, May 11, 2026Time: 9:30 a.m. ETWebcast: https://investors.telos.com/news-and-events/events   An on-demand replay of the webcast will be available on the Company’s investor relations website. About Telos CorporationTelos Corporation (NASDAQ: TLS) empowers and protects the world’s most security-conscious organizations with efficient,...

Continue reading

Getty Images Selected as Official Photographer of 2026 Met Gala

A Media Snippet accompanying this announcement is available by clicking on this link. NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) — Getty Images (NYSE: GETY), a preeminent global visual content creator and marketplace, has once again been named the Official Photographer of The Metropolitan Museum of Art’s Costume Institute Benefit, more commonly known as The Met Gala. Taking place on May 4, fashion’s most prestigious event will bring together icons from the world of fashion, film, music, sports, business and art. Getty Images’ award-winning entertainment photographers and videographers will deliver unparalleled coverage of the invitation-only event for the eighth consecutive year. Employing remote cameras and a mobile film studio, the team will capture every angle – from red carpet arrivals and departures to candid images inside...

Continue reading

Critical Metals to Acquire European Lithium

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) — Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp.” or the “Company”), a leading critical mineral mining company, today announced the signing of a letter of intent whereby Critical Metals has proposed to acquire all of the outstanding shares of European Lithium Ltd. (ASX: EUR) (“European Lithium”) (the “Proposed Transaction”). Under the Proposed Transaction, European Lithium shareholders will receive 0.035 shares of Critical Metals for each European Lithium share held (the “Exchange Ratio”). Based on the Exchange Ratio and considering the unaffected closing price of Critical Metals and the US Dollar to Australian Dollar exchange rate on April 22, 2026 (the “Measurement Date”), the total aggregate consideration payable to European Lithium equity holders is approximately...

Continue reading

Adial Pharmaceuticals Submits Application to FDA Commissioner’s National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program

Voucher application details focus on AUD as a major driver of the U.S. substance use crisis and the genetic targeting of AD04’s role in providing a treatment option for patients where existing treatments inadequately address patient outcomes GLEN ALLEN, Va., April 27, 2026 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, announced the submission of the AD04 product application for consideration of the Food & Drug Administration (FDA) Commissioner’s National Priority Voucher Pilot Program (CNPV). Announced in 2025, the CNPV program is designed to speed up the FDA review process for drugs that address one of five key U.S. national health...

Continue reading

TeaPot® Declares Second Saturday in May “Take Your Mom to the Dispensary Day”

Cannabis iced tea brand is celebrating mom and launching new THC-infused raspberry black teaTeaPot is celebrating mom and launching new THC-infused raspberry black teaTeaPot Extra Raspberry Black Tea is made with real black tea and infused with 10mg of Live Rosin THC and 10mg of CBG – “the mother of all cannabinoids.”TeaPot declares second Saturday in May “Take Your Mom to the Dispensary Day”Take Your Mom to The Dispensary on May 9, 2026Toronto, April 27, 2026 (GLOBE NEWSWIRE) — Fresh off 4/20, TeaPot®, the award-winning cannabis-infused iced tea brand from The Boston Beer Company’s Canadian-based subsidiary (BBCCC, Inc.) declares a new holiday worth celebrating: Take Your Mom to the Dispensary Day. Since cannabis was legalized in Canada in 2018, consumption by older adults has risen more rapidly than any other...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.